Financial comparisons The Carlyle Group Inc.
Equities
CG
US14316J1088
Investment Management & Fund Operators
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.58 USD | +0.77% |
|
-6.69% | +4.14% |
02-03 | Baxter's Kidney Care Segment Vantive Acquired by Carlyle Group | MT |
01-31 | Shareholder activists demand clear strategy from thyssenkrupp CEO | RE |
Revenues | Net margin | EBIT margin | ROE | ROA | Leverage | ||
---|---|---|---|---|---|---|---|
3.41B | 17.87% | 42.01% | 19.58% | 5.52% | 4.75x | ||
5.6B | 65.71% | 74.74% | 16.86% | 1.19% | 6.41x | ||
9.69B | 52.21% | 63.56% | 69.94% | 12.22% | 1.33x | ||
3.01B | 23.31% | 34.26% | 40.34% | 3.01% | - | ||
3.54B | 36.36% | 46.75% | 10.40% | 3.60% | 0.9x | ||
1.66B | 3.27% | 60.09% | 59.23% | 10.48% | 1.71x | ||
8.48B | 5.48% | 20.21% | 10.45% | 4.08% | -0.24x | ||
380M | 61.41% | 60.22% | 29.47% | 27.58% | -0.01x | ||
452M | 31.18% | 54.40% | 44.98% | - | 0.3x | ||
10.69B | 2.33% | 45.50% | 3.58% | 0.18% | - | ||
500M | - | - | - | - | - | ||
551M | 40.30% | 47.20% | 22.03% | - | - | ||
1.53B | 5.22% | 40.83% | 2.50% | 6.76% | -0.53x | ||
967M | 38.33% | 55.75% | 44.27% | 24.24% | -1.4x | ||
871M | 26.49% | 95.83% | 2.68% | 1.43% | 5.75x | ||
1.79B | 28.51% | 12.12% | 16.90% | 6.49% | 6.33x | ||
245M | 54.35% | 68.12% | 29.54% | 26.89% | - | ||
3.37B | 7.83% | 28.21% | 5.93% | 2.55% | -0.69x | ||
490M | 26.36% | 33.59% | 39.10% | 18.31% | - | ||
Average | 3.01B | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | 1.89x | |
Weighted average by Cap. | 5.75B | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | 3.30x |
- Stock Market
- Equities
- CG Stock
- Sector The Carlyle Group Inc.
- Financial comparisons

MarketScreener is also available in this country: United States.
Switch edition